Boehringer Ingelheim Pharmaceuticals, Inc.
Member Type
Associate
Organization Type
Manufacturer
Description
Value Through Innovation is Our Vision Improving the health and lives of humans and animals is the goal of the research-driven biopharmaceutical company Boehringer Ingelheim. The focus is on diseases in areas with a high unmet medical need. The company therefore concentrates on developing innovative therapies that can improve and extend lives. In Animal Health, Boehringer Ingelheim is one of the world’s leading providers of vaccines, therapeutics and preventative care offering that protect animals from disease and pain. Family-owned since its foundation in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Our aim is to transform the lives of patients –across generations. This goal inspires all of our over 53,000 employees who create value through innovation. In 2022, Boehringer Ingelheim achieved net sales of 24.1 billion euros.
Contact Information
900 Ridgebury Road
Ridgefield, CT 06877-0368
http://www.boehringer-ingelheim.com(800)344-4095
Services Offered
Branded
HIV/AIDS (HIV)
Staff
-
Roberts, Justin
Associate Director, Contract Channel Implementation, Boehringer Ingelheim Pharmaceuticals, Inc. -
Rotkewicz, Kelly
Executive Director, Sustainability, US Strategy & Operations, Boehringer Ingelheim Pharmaceuticals, Inc. -
Schlachta, Steven
SR AD Access & Reimbursement, Boehringer Ingelheim Pharmaceuticals, Inc. -
Schoen, Johannes
Boehringer Ingelheim Pharmaceuticals, Inc. -
Segnere, Scott
Executive Director, Trade & Specialty Distribution, Boehringer Ingelheim Pharmaceuticals, Inc. -
Skandera-Sanford, Laura
HP Country Commercial - Market Access, Boehringer Ingelheim Pharmaceuticals, Inc. -
Towers, Lori
National Account Director, Boehringer Ingelheim Pharmaceuticals, Inc. -
Wilson, Amanda
Security Manager, Athens, GA, Boehringer Ingelheim Pharmaceuticals, Inc. -
Wright, Stephen
Executive Director, Payor Sales, Boehringer Ingelheim Pharmaceuticals, Inc.